Skip to main content
Journal ArticleOPEN ACCESS

Genomic Alterations in Advanced Esophageal Cancer May Lead to Subtype-Specific Therapies

  • Forde P
  • Kelly R
The Oncologist (2013) 18(7) 823-832
DOI: 10.1634/theoncologist.2013-0130
11Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Describe the current status of targeted therapy for esophageal cancer. Describe the molecular aberrations which are thought to drive the development and spread of esophageal cancer in order to identify promising targets for specific inhibition.

Cite

CITATION STYLE

APA

Forde, P. M., & Kelly, R. J. (2013). Genomic Alterations in Advanced Esophageal Cancer May Lead to Subtype-Specific Therapies. The Oncologist, 18(7), 823–832. https://doi.org/10.1634/theoncologist.2013-0130

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free